Project Grant R03AG104308
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $320K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Waltham, MA 02451, USA
Similar Awards
- The National Institute on Aging awarded the University of California, Los Angeles $623,176 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on modifiable risk factors for Alzheimer's disease and related dementias among individuals aged 90 and older. The research triangulates evidence across four data sources—the LifeAfter90 Study (1,397 participants, all aged 90), the 90+ Study (1,630 participants, all aged 90), the Health and Retirement Study (3,359...
- The National Institute on Aging awarded the University of Massachusetts Medical School $643,089 under the Aging Research program (CFDA 93.866) on September 30, 2025, to conduct objective medication self-administration (MSA) assessments as early-stage markers of cognitive impairment and Alzheimer's disease and related dementias (ADRD). The research will cross-sectionally and longitudinally associate MSA errors and self-overestimation with behavioral and brain-based ADRD biomarkers, cognitive...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded $674,088 to The General Hospital Corporation (doing business as Massachusetts General Hospital) on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate how environmental and psychosocial exposures shape Alzheimer's disease and related dementias outcomes. The project introduces a novel exposome-health outcomes framework tailored to real-world data, particularly Medicare...
- The National Institute on Aging awarded Massachusetts General Hospital (doing business as The General Hospital Corporation) $679,058 under the Aging Research program (CFDA 93.866) on July 1, 2026, to investigate whether participation in the Geriatric Emergency Department Accreditation (GEDA) program improves emergency care processes and clinical outcomes for older adults with dementia. The study combines three population-based datasets from 2022–2024 (NEDI-USA for emergency department...
- The National Institute on Aging awarded Wake Forest University Health Sciences $633,510 on September 1, 2026, under the Aging Research program (CFDA 93.866) to examine the impact of home-based medical care and telemedicine use on dementia care outcomes among Medicare enrollees with Alzheimer's disease and related dementias. The project will study home-based medical care delivery—house calls by physicians and advanced care providers—and telemedicine use among persons living with Alzheimer's...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The National Institute on Aging awarded the National Bureau of Economic Research Inc. $427,646 on September 1, 2026, under the Aging Research program (CFDA 93.866) to trace mid-life mortality of birth cohorts born approximately 1940–1960 in the United States by place, time, and family factors. The research combines large-scale administrative datasets—the Numident, Bureau of the Census Numident Mortality Detail file, and Mortality Linkage Project data, containing more than 3.5 million death...
- The National Institute on Aging awarded the University of Pennsylvania $198,164 on October 29, 2025, under the Aging Research program (CFDA 93.866) to support an Individual National Research Service Award (NRSA) for predoctoral research training focused on dementia-friendly hospitalization practices and family caregiver inclusion. The award funds research training that enables the applicant, an acute care nurse and clinical nurse specialist, to develop competence in understanding the care of...
- The National Institute on Aging awarded Duke University $1.597 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to support research on epitranscriptomic regulation of microglia in Alzheimer's disease. The research investigates how m6a methylation of adenosine residues in messenger RNA regulates microglial cell function and transitions between resting and activated states during Alzheimer's disease pathogenesis, with the goal of identifying novel...
- The National Institute on Aging awarded Brigham & Women's Hospital Inc. $943,368 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate health care contact days—days older adults spend obtaining health care outside the home—and their impact on patient outcomes. The research addresses three primary aims. Aim 1 employs semi-structured interviews and focus groups across two large health systems serving multiple populations in five states to elicit perspectives...